@prefix dcterms: . @prefix ns1: . @prefix this: . @prefix sub: . @prefix schema: . @prefix np: . @prefix rdf: . @prefix nt: . @prefix xsd: . @prefix rdfs: . @prefix orcid: . @prefix bl: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { bl:category bl:Disease . sub:association rdf:object ; rdf:predicate bl:treats; rdf:subject ; a rdf:Statement; rdfs:label "vraylar r is indicated for the treatment of schizophrenia in adults see clinical studies 14 1 acute treatment of manic or mixed episodes associated with bipolar i disorder in adults see clinical studies 14 2 vraylar is an atypical antipsychotic indicated for the treatment of schizophrenia in adults 1 acute treatment of manic or mixed episodes associated with bipolar i disorder in adults 1"; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:provided_by ; bl:relation schema:TreatmentIndication . bl:category bl:Drug . } sub:provenance { sub:assertion ns1:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "FvWEihw1KM9PZQitV3DzmHm4YlMaA39aw5R4gXpuFXr6lKyouxg6v1mKPKejOm+8rJjvY1TOcX94nhsXLOHVXbL6skdonT7RY9UUba3PoByC7+5jnDPjeUWwjArjYDxVbNX2poPcDYYgFInhL9rqGJR67pntFSj1MOcPwwkSBEk="; npx:hasSignatureTarget this: . this: dcterms:created "2021-07-03T15:32:14.898+02:00"^^xsd:dateTime; dcterms:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate ; nt:wasCreatedFromPubinfoTemplate ; nt:wasCreatedFromTemplate . }